Achyranthes aspera (Apamarg) leaf extract inhibits human pancreatic tumor growth in athymic mice by apoptosis

Journal of Ethnopharmacology

Volumn 142, Issue 2, 2012, Pages 523-530

  Subbarayan, Pochi R ^a   Sarkar, Malancha ^a   Nagaraja Rao, Shamaladevi ^a   Philip, Sakhi ^a   Kumar, Pradeep ^b   Altman, Norman ^a   Reis, Isildinha ^a   Ahmed, Mansoor ^a   Ardalan, Bach ^a   Lokeshwar, Bal L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Rameshwar Research and Development Corporation   (India)

Author keywords

Akt inhibition; BxPC 3 luc 2; Caspase 3 activation; Ethnobotanicals; TUNEL assay; Xenograft

Indexed keywords

ACHYRANTHES ASPERA EXTRACT; CASPASE 3; MESSENGER RNA; PROTEIN KINASE B;

ACHYRANTHES ASPERA; ADVERSE DRUG REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BEHAVIOR; BODY WEIGHT; CANCER CELL; CANCER SURVIVAL; CONTROLLED STUDY; DIARRHEA; DRUG TOXICITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EYE REDNESS; GENE EXPRESSION; GENE INDUCTION; GENETIC ANALYSIS; HEMATOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LETHARGY; MOUSE; NICK END LABELING; NONHUMAN; PANCREAS CANCER; PLANT LEAF; REAL TIME POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT;

ACHYRANTHES; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; GENE EXPRESSION; HUMANS; INJECTIONS, INTRAPERITONEAL; MEDICINE, AYURVEDIC; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ACHYRANTHES ASPERA; MUS;

EID: 84862834886     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.05.030     Document Type: Article

References (22)

1. M.S. Akhtar, and J. Iqbal Evaluation of the hypoglycaemic effect of Achyranthes aspera in normal and alloxan-diabetic rabbits J.Ethnopharmacol 31 1991 49 57
2. N.K. Basu The Chemical Constitution of Achyranthine. J.&Proc.Inst. Chem. 29 1957 73 74
3. H.A. Burris III, M.J. Moore, J. Andersen, M.R. Green, M.L. Rothenberg, M.R. Modiano, M.C. Cripps, R.K. Portenoy, A.M. Storniolo, P. Tarassoff, R. Nelson, F.A. Dorr, C.D. Stephens, and D.D. Von Hoff Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J. Clin. Oncol. 15 1997 2403 2413
4. A. Chakraborty, A. Brantner, T. Mukainaka, Y. Nobukuni, M. Kuchide, T. Konoshima, H. Tokuda, and H. Nishino Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis Cancer Lett. 177 2002 1 5
5. T. Efferth, P.C. Li, V.S. Konkimalla, and B. Kaina From traditional Chinese medicine to rational cancer therapy Trends Mol. Med. 13 2007 353 361
6. A.B. Gokhale, A.S. Damre, K.R. Kulkami, and M.N. Saraf Preliminary evaluation of anti-inflammatory and anti-arthritic activity of S. lappa, A. speciosa and A. aspera Phytomedicine 9 2002 433 437
7. B.R. Goyal, R.K. Goyal, and A.A. Mehta Phyto-pharmcology of Achyranthes aspera: A Review Pharmacognosy Reviews 1 2007 143 150
8. R.H. Hruban, A. Maitra, R. Schulick, D. Laheru, J. Herman, S.E. Kern, and M. Goggins Emerging molecular biology of pancreatic cancer Gastrointest.Cancer Res. 2 2008 S10 S15
9. S. Jones, X. Zhang, D.W. Parsons, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, H. Kamiyama, A. Jimeno, S.M. Hong, B. Fu, M.T. Lin, E.S. Calhoun, M. Kamiyama, K. Walter, T. Nikolskaya, Y. Nikolsky, J. Hartigan, D.R. Smith, M. Hidalgo, S.D. Leach, A.P. Klein, E.M. Jaffee, M. Goggins, A. Maitra, C. Iacobuzio-Donahue, J.R. Eshleman, S.E. Kern, R.H. Hruban, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V.E. Velculescu, and K.W. Kinzler Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 2008 1801 1806
10. V.K. Kapoor, and H. Singh Isolation of Betaine from Achyranthes aspera Linn Indian J. Chem. 4 1966 461
11. V.K. Kapoor, and H. Singh Investigation of achyranthes aspera Linn Indian J. Pharm. 29 1967 285 288
12. H.N. Khastgir, and P. Sengupta Oleanolic acid from Achyranthes aspera Linn J.Indian Chem. Soc. 35 1958 529 530
13. B. Kraus, and H. Wolff High Content Analysis with AxioVision ASSAYbuilder: Applications in Pharmaceutical Biology Biotechniques 44 2008 820 823
14. A. Mali, H.A. Maheshwari, and D.D. Santani Pharmacological and toxicological activities of alkaloid of achyranthes aspera Linn J.Indian Aca.Foren.Sci 29 1990 53 58
15. C. Mazzaccara, G. Labruna, G. Cito, M. Scarfo, M. De Felice, L. Pastore, and L. Sacchetti Age-Related Reference Intervals of the Main Biochemical and Hematological Parameters in C57BL/6 J, 129SV/EV and C3H/HeJ Mouse Strains PLoS.One 3 2008 e3772
16. P.Y. Muller, H. Janovjak, A.R. Miserez, and Z. Dobbie Processing of gene expression data generated by quantitative real-time RT-PCR Biotechniques 32 2002 1372 1379
17. N.C. Neogi, R.S. Rathor, A.D. Dhreshtha, and D.K. Banerjee Studies on the anti-inflamatory and anti-arthritic activity of achyranthine Indian J. Pharm. 1 1969 37 47
18. D.J. Newman Natural products as leads to potential drugs: an old process or the new hope for drug discovery J.Med. Chem. 51 2008 2589 2599
19. E.N. Smith, and R.T. Taylor Acute toxicity of methanol in the folate-deficient acatalasemic mouse Toxicology 25 1982 271 287
20. P.R. Subbarayan, K. Lee, and B. Ardalan Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU Anticancer Res. 30 2010 1157 1162
21. P.R. Subbarayan, M. Sarkar, S. Impellizzeri, F. Raymo, B.L. Lokeshwar, P. Kumar, R.P. Agarwal, and B. Ardalan Anti-proliferative and anti-cancer properties of Achyranthes aspera: specific inhibitory activity against pancreatic cancer cells J. Ethnopharmacol. 131 2010 78 82
22. X. Wan, and L.J. Helman Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II- overexpressing rhabdomyosarcomas cells Oncogene 22 2003 8205 8211